Complex Biologics CDMO+ CRO - Abzena

Our Manifesto

Our focus, who we are & what we do

Moving medicine forward

Driven by our values and passion for what we do, we are a CDMO + CRO ready to take on the most complex challenges in biologics, bioconjugates, and ADC drug development. Let us de-risk and streamline the development and manufacture of your novel treatments so that you can accelerate from discovery through to commercialization. Let’s turn ideas into action and get your next-generation medicines to patients, faster. Together, we are moving medicine forward.

Our manifesto reflects our focus, who we are and what we do.

Contact Us
LabZient™: Rapid Analytical Data

20+ years of moving medicine forwards

Since 2001, Abzena has evolved from its early days as PolyTherics and Antitope respectively into a leading bioconjugates and biologics CDMO. We have always been focused on our values rooted in scientific innovation, offering our customers a personalized experience. With that in mind, in 2024 we decided to better highlight the difference that we can make together with our clients to improve patients’ lives. Leveraging our innate passion for science, and creating revolutionary new medicines is why moving medicine forward truly matters to us.

Our History

Helping our customers move into the future

“We holistically support our customers, turning their idea or sequence into a marketable product by fortifying crucial tasks like optimal drug design and characterization, investigational new drug (IND) submissions, and final product development and manufacturing activities.”

Matt Stober, CEO of Abzena.

Latest News & Insights

Articles

Biocompare.com: Addressing Antibody-Drug Conjugate Development Challenges

Read More

Blog

Blog: Digital Brand Refresh – The Launch of a Dynamic, New Abzena.com

Read More

Articles

Pharmaceutical Technology: Forging Ahead in Formulation

Read More